Key facts
- This page summarizes Adam Lezack's Form 4 filing for Beta Bionics, Inc. (BBNX).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 03 Feb 2025, 20:30.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Additional SEC filing notes
Footnote F1
The shares subject to this option shall vest in 36 equal monthly installments measured from December 12, 2023.
Footnote F2
Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock.